Investors chew on Jaws' stunning $4.4bn SPAC deal for Cano Health

The deal highlights the fact that PIPE investors in a SPAC are underwriting to different financial metrics than prospective PE buyers – leading to much larger valuations in some cases.

DealsHealthcareFeaturedTop Stories